APA (7th ed.) Citation

Y, X., J, X., BL, M., A, R., W, H., Z, S., . . . Y, S. (2024). Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy. Cell, 187(24), 6966. https://doi.org/10.1016/j.cell.2024.09.043

Chicago Style (17th ed.) Citation

Y, Xiang, et al. "Adaptive Multi-epitope Targeting and Avidity-enhanced Nanobody Platform for Ultrapotent, Durable Antiviral Therapy." Cell 187, no. 24 (2024): 6966. https://doi.org/10.1016/j.cell.2024.09.043.

MLA (9th ed.) Citation

Y, Xiang, et al. "Adaptive Multi-epitope Targeting and Avidity-enhanced Nanobody Platform for Ultrapotent, Durable Antiviral Therapy." Cell, vol. 187, no. 24, 2024, p. 6966, https://doi.org/10.1016/j.cell.2024.09.043.